SEC Form 4 · accession 0001179110-15-007686
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Schoeneck
Officer — President and CEO · Director
Period of report
May 12, 2015
Accepted (ET)
May 12, 2015 · 9:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3 | May 12, 2015 | M | 30,000 | $6.11 | A | 45,732 | D | |
| Common StockF3 | May 12, 2015 | M | 11,127 | $8.36 | A | 56,859 | D | |
| Common StockF3 | May 12, 2015 | M | 4,552 | $6.11 | A | 61,411 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $6.11 | May 12, 2015 | M | 30,000 | D | — | Jan 12, 2022 | Common Stock | 30,000 | 37,771 | D |
| Stock OptionF2 | $8.36 | May 12, 2015 | M | 11,127 | D | — | Apr 18, 2021 | Common Stock | 11,127 | 0 | D |
| Stock OptionF1 | $6.11 | May 12, 2015 | M | 4,552 | D | — | Jan 12, 2022 | Common Stock | 4,552 | 8,677 | D |
Explanation of responses
- F1Exercisable in 48 equal monthly installments
- F21/8th of these stock options are exercisable on October 18th, 2011 and the balance are exercisable in 42 equal monthly installments.
- F3Amount does not include 221,306 shares of common stock held indirectly by family trust.